Published in Appl Environ Microbiol on August 01, 1992
Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev (2003) 6.67
Microorganisms resistant to free-living amoebae. Clin Microbiol Rev (2004) 4.22
Interaction of Mycobacterium avium with environmental amoebae enhances virulence. Infect Immun (1997) 3.14
Amoebae as training grounds for intracellular bacterial pathogens. Appl Environ Microbiol (2005) 2.59
Legionella pneumophila utilizes the same genes to multiply within Acanthamoeba castellanii and human macrophages. Infect Immun (1999) 2.32
Utilization of similar mechanisms by Legionella pneumophila to parasitize two evolutionarily distant host cells, mammalian macrophages and protozoa. Infect Immun (1997) 2.29
Interaction of Legionella pneumophila with Acanthamoeba castellanii: uptake by coiling phagocytosis and inhibition of phagosome-lysosome fusion. Infect Immun (1996) 2.19
Invasion of protozoa by Legionella pneumophila and its role in bacterial ecology and pathogenesis. Appl Environ Microbiol (1998) 2.07
Molecular pathogenesis of infections caused by Legionella pneumophila. Clin Microbiol Rev (2010) 2.04
Parachlamydiaceae: potential emerging pathogens. Emerg Infect Dis (2002) 1.95
Inorganic polyphosphate in the origin and survival of species. Proc Natl Acad Sci U S A (2004) 1.94
Intraphagocytic growth induces an antibiotic-resistant phenotype of Legionella pneumophila. Antimicrob Agents Chemother (1995) 1.63
Identification of macrophage-specific infectivity loci (mil) of Legionella pneumophila that are not required for infectivity of protozoa. Infect Immun (1998) 1.54
Grazing protozoa and the evolution of the Escherichia coli O157:H7 Shiga toxin-encoding prophage. Proc Biol Sci (2007) 1.44
Current and emerging Legionella diagnostics for laboratory and outbreak investigations. Clin Microbiol Rev (2015) 1.41
Poly-3-hydroxybutyrate in Legionella pneumophila, an energy source for survival in low-nutrient environments. Appl Environ Microbiol (1999) 1.37
Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev (2003) 1.33
Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials. Antimicrob Agents Chemother (2000) 1.29
Long-term survival of Legionella pneumophila in the viable but nonculturable state after monochloramine treatment. Curr Microbiol (2008) 1.24
Legionella, protozoa, and biofilms: interactions within complex microbial systems. Microb Ecol (2009) 1.18
Heterogeneity in the attachment and uptake mechanisms of the Legionnaires' disease bacterium, Legionella pneumophila, by protozoan hosts. Appl Environ Microbiol (1998) 1.15
Enhanced survival of Salmonella enterica in vesicles released by a soilborne Tetrahymena species. Appl Environ Microbiol (2005) 1.13
Impact of Chlorine and Heat on the Survival of Hartmannella vermiformis and Subsequent Growth of Legionella pneumophila. Appl Environ Microbiol (1993) 1.10
Passage through Tetrahymena tropicalis triggers a rapid morphological differentiation in Legionella pneumophila. J Bacteriol (2008) 0.99
Cellular microbiology and molecular ecology of Legionella-amoeba interaction. Virulence (2013) 0.99
Stimulatory effect of cooling tower biocides on amoebae. Appl Environ Microbiol (1993) 0.98
Inorganic polyphosphate in Dictyostelium discoideum: influence on development, sporulation, and predation. Proc Natl Acad Sci U S A (2005) 0.96
Infection of Acanthamoeba castellanii with Mycobacterium bovis and M. bovis BCG and survival of M. bovis within the amoebae. Appl Environ Microbiol (2003) 0.90
Icm/dot-independent entry of Legionella pneumophila into amoeba and macrophage hosts. Infect Immun (2004) 0.90
Influence of Acanthamoeba castellanii on intracellular growth of different Legionella species in human monocytes. Appl Environ Microbiol (2000) 0.88
Balamuthia mandrillaris, free-living ameba and opportunistic agent of encephalitis, is a potential host for Legionella pneumophila bacteria. Appl Environ Microbiol (2005) 0.87
Replication of Legionella Pneumophila in Human Cells: Why are We Susceptible? Front Microbiol (2010) 0.86
Cellular response of the amoeba Acanthamoeba castellanii to chlorine, chlorine dioxide, and monochloramine treatments. Appl Environ Microbiol (2011) 0.81
HACCP-Based Programs for Preventing Disease and Injury from Premise Plumbing: A Building Consensus. Pathogens (2015) 0.79
Density of environmental Acanthamoeba and their responses to superheating disinfection. Parasitol Res (2013) 0.79
A regulatory feedback loop between RpoS and SpoT supports the survival of Legionella pneumophila in water. Appl Environ Microbiol (2014) 0.79
Free-Living Amoebae as Hosts for and Vectors of Intracellular Microorganisms with Public Health Significance. Viruses (2017) 0.75
Legionella pneumophila: The Paradox of a Highly Sensitive Opportunistic Waterborne Pathogen Able to Persist in the Environment. Front Microbiol (2016) 0.75
Application of Hydrogen Peroxide as an Innovative Method of Treatment for Legionella Control in a Hospital Water Network. Pathogens (2017) 0.75
Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens. J Clin Microbiol (1981) 11.09
Cellular fatty acid composition of isolates from Legionnaires disease. J Clin Microbiol (1977) 10.84
Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother (1988) 5.10
Development of a standardized subgrouping scheme for Legionella pneumophila serogroup 1 using monoclonal antibodies. J Clin Microbiol (1986) 4.45
Current views on the relationships between amoebae, legionellae and man. Isr J Med Sci (1986) 3.49
Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob Agents Chemother (1990) 3.38
Isolation of Legionella pneumophila from clinical specimens via amoebae, and the interaction of those and other isolates with amoebae. J Clin Pathol (1983) 2.82
Survival of Legionella pneumophila within cysts of Acanthamoeba polyphaga following chlorine exposure. J Appl Bacteriol (1990) 2.40
Effects of cytochalasin D and methylamine on intracellular growth of Legionella pneumophila in amoebae and human monocyte-like cells. Infect Immun (1991) 1.88
Laboratory studies of disinfectants against Legionella pneumophila. Appl Environ Microbiol (1980) 1.83
Legionella pneumophila in cooling water systems. Report of a survey of cooling towers in London and a pilot trial of selected biocides. J Hyg (Lond) (1982) 1.72
Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents. J Antimicrob Chemother (1985) 1.53
Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother (1990) 1.49
Media for study of growth kinetics and envelope properties of iron-deprived bacteria. J Clin Microbiol (1987) 1.33
Survival and growth of Legionella species in the environment. Soc Appl Bacteriol Symp Ser (1991) 1.20
Role of keto acids and reduced-oxygen-scavenging enzymes in the growth of Legionella species. J Clin Microbiol (1986) 1.17
Interaction of some polyhexamethylene biguanides and membrane phospholipids in Escherichia coli. J Appl Bacteriol (1984) 1.17
Relationship between free amoeba and Legionella: studies in vitro and in vivo. Zentralbl Bakteriol (1990) 1.06
Biocidal control of legionellae. Isr J Med Sci (1986) 1.03
Barrier properties of the gram-negative cell envelope towards high molecular weight polyhexamethylene biguanides. J Appl Bacteriol (1990) 0.87
Survival of Legionella pneumophila. Med Lab Sci (1986) 0.87
Growth inhibitory and biocidal activity of some isothiazolone biocides. J Appl Bacteriol (1990) 0.84
Mutagenicity of two non-formaldehyde-forming antimicrobial agents. Food Chem Toxicol (1983) 0.81
Dose-response assessments of Kathon biocide (I). Diagnostic use and diagnostic threshold patch testing with sensitized humans. Contact Dermatitis (1985) 0.80
Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med (1995) 6.77
Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J Antimicrob Chemother (1988) 5.10
Prevalence and predictive value of intermittent viremia with combination hiv therapy. JAMA (2001) 3.73
Sensitivity of biofilms to antimicrobial agents. J Appl Bacteriol (1993) 3.39
Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob Agents Chemother (1990) 3.38
The influence of environment on envelope properties affecting survival of bacteria in infections. Annu Rev Microbiol (1985) 3.24
Trojan horses of the microbial world: protozoa and the survival of bacterial pathogens in the environment. Microbiology (1994) 2.83
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med (2001) 2.75
Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm. J Bacteriol (2004) 2.74
Iterative methods for the three-dimensional reconstruction of an object from projections. J Theor Biol (1972) 2.66
Susceptibility of Pseudomonas aeruginosa and Escherichia coli biofilms towards ciprofloxacin: effect of specific growth rate. J Antimicrob Chemother (1991) 2.47
Loss of sensitivity to EDTA by Pseudomonas aeruginosa grown under conditions of Mg-limitation. J Gen Microbiol (1968) 2.47
Extracellular products as mediators of the formation and detachment of Pseudomonas fluorescens biofilms. FEMS Microbiol Lett (1998) 2.46
A simple diagnostic milk medium for Pseudomonas aeruginosa. J Clin Pathol (1970) 2.44
Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol (2003) 2.40
Susceptibility of bacterial biofilms to tobramycin: role of specific growth rate and phase in the division cycle. J Antimicrob Chemother (1990) 2.23
The DNA sequence of the mercury resistance operon of the IncFII plasmid NR1. J Mol Appl Genet (1984) 1.98
Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial. Heart (2001) 1.93
Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J Virol (2002) 1.91
In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions. Infect Immun (1985) 1.86
Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res (1983) 1.86
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
The role of the O and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis. J Gen Microbiol (1983) 1.81
Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood (1994) 1.79
Nurse triage for house call requests in a Tyneside general practice: patients' views and effect on doctor workload. Br J Gen Pract (1998) 1.79
Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J Virol (2002) 1.77
Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood (1997) 1.73
Role of divalent cations in the action of polymyxin B and EDTA on Pseudomonas aeruginosa. J Gen Microbiol (1969) 1.73
Bombesin-like immunoreactivity in the lung. Nature (1978) 1.73
Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature (1983) 1.70
"Liver function tests" are not always tests of liver function. Am J Hematol (2001) 1.67
The social competition hypothesis of depression. Br J Psychiatry (1994) 1.67
Intraphagocytic growth induces an antibiotic-resistant phenotype of Legionella pneumophila. Antimicrob Agents Chemother (1995) 1.63
Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology (1982) 1.58
Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J Virol (2001) 1.57
Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood (2001) 1.55
Influence of substrate limitation and growth phase on sensitivity to antimicrobial agents. J Antimicrob Chemother (1985) 1.53
Podocytes in glomerulus of rat kidney express a characteristic 44 KD protein. J Histochem Cytochem (1991) 1.51
Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet (1998) 1.51
Micronodulation: ultrasonographic sign of Hashimoto thyroiditis. J Ultrasound Med (1996) 1.51
Localization of an insulin-like peptide in brains of two flies. Cell Tissue Res (2001) 1.50
Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies. Antimicrob Agents Chemother (1990) 1.49
The relation of entrapment, shame and guilt to depression, in carers of people with dementia. Aging Ment Health (2006) 1.48
Low magnesium and phospholipid content of cell wals of Pseudomonas aeruginosa resistant to polymyxin. Nature (1970) 1.47
Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature (1977) 1.47
Biofilms and beta-lactam activity. J Antimicrob Chemother (1998) 1.46
Growth rate control of adherent bacterial populations. Appl Environ Microbiol (1989) 1.45
Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science (1992) 1.45
Influence of growth rate and nutrient limitation on the gross cellular composition of Pseudomonas aeruginosa and its resistance to 3- and 4-chlorophenol. J Bacteriol (1978) 1.44
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab (1981) 1.42
Influence of intra-amoebic and other growth conditions on the surface properties of Legionella pneumophila. Infect Immun (1993) 1.41
Nutrient depletion and antibiotic susceptibility. J Antimicrob Chemother (1977) 1.41
Recognising phenytoin therapy as a cause of thickening of the eyelids and paranasal region. J Plast Reconstr Aesthet Surg (2011) 1.40
Problems in identifying predictors and correlates of weight loss and maintenance: implications for weight control therapies based on behaviour change. Obes Rev (2011) 1.39
The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas (1992) 1.38
Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins. Infect Immun (1997) 1.38
Relation between cation and lipid content of cell walls of Pseudomonas aeruginosa, Proteus vulgaris and Klebsiella aerogenes and their sensitivity to polymyxin B and other antibacterial agents. J Pharm Pharmacol (1972) 1.37
An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study). J Infect Dis (2011) 1.37
The influence of the O and K antigens of Klebsiella aerogenes on surface hydrophobicity and susceptibility to phagocytosis and antimicrobial agents. J Med Microbiol (1986) 1.36
Ultrastructure of the encapsulation of Plasmodium cynomolgi (B strain) on the midgut of a refractory strain of Anopheles gambiae. J Parasitol (1988) 1.36
Growth-rate-independent killing by ciprofloxacin of biofilm-derived Staphylococcus epidermidis; evidence for cell-cycle dependency. J Antimicrob Chemother (1992) 1.35
Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency. J Infect Dis (1998) 1.35
Insulin stimulates ecdysteroid production through a conserved signaling cascade in the mosquito Aedes aegypti. Insect Biochem Mol Biol (1999) 1.35
Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin Immunol (1999) 1.34
Deliberate overfeeding in women and men: energy cost and composition of the weight gain. Br J Nutr (1986) 1.33
Media for study of growth kinetics and envelope properties of iron-deprived bacteria. J Clin Microbiol (1987) 1.33
The power and omnipotence of voices: subordination and entrapment by voices and significant others. Psychol Med (2000) 1.32
Adsorption of I-131-triiodothyronine (T3) from serum by charcoal as an in vitro test of thyroid function. J Lab Clin Med (1965) 1.31
Possible involvement of the division cycle in dispersal of Escherichia coli from biofilms. J Bacteriol (1990) 1.30
Composition of Pseudomonas aeruginosa slime. Biochem J (1969) 1.30
Inocula for antimicrobial sensitivity testing: a critical review. J Antimicrob Chemother (1987) 1.29
Effect of subinhibitory concentrations of cephalosporins on surface properties and siderophore production in iron-depleted Klebsiella pneumoniae. Antimicrob Agents Chemother (1985) 1.26
Effect of biofilm culture upon the susceptibility of Staphylococcus epidermidis to tobramycin. J Antimicrob Chemother (1992) 1.25
Coaggregation between freshwater bacteria within biofilm and planktonic communities. FEMS Microbiol Lett (2003) 1.25
Release of intracellular Ca2+ and elevation of inositol trisphosphate by secretagogues in parietal and chief cells isolated from rabbit gastric mucosa. Biochim Biophys Acta (1986) 1.24
Mechanisms of the bactericidal activity of low amperage electric current (DC). J Antimicrob Chemother (1997) 1.24
A simple in vitro model for growth control of bacterial biofilms. J Appl Bacteriol (1995) 1.24
Development and characterization of a simple perfused oral microcosm. J Appl Microbiol (2005) 1.23
Effect of nutrient depletion on sensitivity of Pseudomonas cepacia to phagocytosis and serum bactericidal activity at different temperatures. J Gen Microbiol (1983) 1.21
TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis. Clin Immunol (2001) 1.20
Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats. Endocrinology (1982) 1.19
Formation and dispersal of bacterial biofilms in vivo and in situ. J Appl Bacteriol (1993) 1.19
Characteristics of pregnant substance abusers in two cities in the northeast. Am J Drug Alcohol Abuse (1996) 1.19
Effect of growth-rate on resistance of gram-negative biofilms to cetrimide. J Antimicrob Chemother (1990) 1.19
Continuity of care: does it contribute to quality of care? Med Care (1980) 1.17
Interaction of some polyhexamethylene biguanides and membrane phospholipids in Escherichia coli. J Appl Bacteriol (1984) 1.17
Substance P-like immunoreactive nerves in mammalian lung. Invest Cell Pathol (1980) 1.17
An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms. J Antimicrob Chemother (2000) 1.17
Mosquito trypsin: immunocytochemical localization in the midgut of blood-fed Aedes aegypti (L.). Cell Tissue Res (1986) 1.16